Medical Oncology in Scottsdale, AZ
9 verified medical oncology doctors in Scottsdale.
Medical oncologists diagnose and treat cancer, coordinating chemotherapy and other systemic cancer therapies.
NPPES tenure ≠ clinical experience. "Years on NPPES" is time since the physician first registered a National Provider Identifier, not time practicing medicine. Verify current license status with the state medical board.
Dr. Maciej Mrugala, MD
Medical Oncology
CMS Open Payments· $123,851 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$123,851
Total received
27
Transactions
8
Paying companies
Top paying companies
Among the 4,060 medical oncology doctors we've analyzed, about 60% received any industry payment (median $4,500 among those who did). This doctor's total ranks around the 85th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US medical oncology doctors.
Payments to Maciej Mrugala do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Mitesh Borad, MD
Medical Oncology
CMS Open Payments· $175,729 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$175,729
Total received
28
Transactions
11
Paying companies
Top paying companies
Among the 4,060 medical oncology doctors we've analyzed, about 60% received any industry payment (median $4,500 among those who did). This doctor's total ranks around the 87th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US medical oncology doctors.
Payments to Mitesh Borad do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Nageatte Ibrahim, MD
Medical Oncology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. John Bibb, MD
Medical Oncology
CMS Open Payments· $25.47 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$25.47
Total received
1
Transactions
1
Paying companies
Top paying companies
Among the 4,060 medical oncology doctors we've analyzed, about 60% received any industry payment (median $4,500 among those who did). This doctor's total is on the lower end — around the 42th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US medical oncology doctors.
Payments to John Bibb do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Lisa Sproat, MD
Medical Oncology
CMS Open Payments· $115.24 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$115.24
Total received
1
Transactions
1
Paying companies
Top paying companies
Among the 4,060 medical oncology doctors we've analyzed, about 60% received any industry payment (median $4,500 among those who did). This doctor's total is on the lower end — around the 49th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US medical oncology doctors.
Payments to Lisa Sproat do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Erkut Borazanci, MD
Medical Oncology
CMS Open Payments· $592,521 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$592,521
Total received
38
Transactions
5
Paying companies
Top paying companies
Among the 4,060 medical oncology doctors we've analyzed, about 60% received any industry payment (median $4,500 among those who did). This doctor's total is higher than 93% of that group — among the highest recipients.
Benchmark reflects doctors we've analyzed, not all US medical oncology doctors.
Payments to Erkut Borazanci do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Ashish Chintakuntlawar, MD
Medical Oncology
CMS Open Payments· $1,946 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$1,946
Total received
1
Transactions
1
Paying companies
Top paying companies
Among the 4,060 medical oncology doctors we've analyzed, about 60% received any industry payment (median $4,500 among those who did). This doctor's total ranks around the 65th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US medical oncology doctors.
Payments to Ashish Chintakuntlawar do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Rishi Agarwal, MD
Medical Oncology
CMS Open Payments· $466.81 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$466.81
Total received
17
Transactions
10
Paying companies
Top paying companies
Among the 4,060 medical oncology doctors we've analyzed, about 60% received any industry payment (median $4,500 among those who did). This doctor's total ranks around the 57th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US medical oncology doctors.
Payments to Rishi Agarwal do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Amir Azadi, MD
Medical Oncology
CMS Open Payments· $12,589 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$12,589
Total received
48
Transactions
16
Paying companies
Top paying companies
Among the 4,060 medical oncology doctors we've analyzed, about 60% received any industry payment (median $4,500 among those who did). This doctor's total ranks around the 74th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US medical oncology doctors.
Payments to Amir Azadi do not imply any wrongdoing. Many are meals, education, or research support.